Akaki CMY, Martínez LE, Vega MME, Toussaint CS

Idioma: Español
Referencias bibliográficas: 14
Paginas: 168-169
Archivo PDF: 158.09 Kb.

FRAGMENTO

El dermatofibrosarcoma protuberans (dfsp) es un tumor cutáneo, fibrohistiocítico, poco frecuente, localmente agresivo que infiltra dermis y tejido celular subcutáneo, con grado de malignidad intermedio y alto riesgo de recurrencia, aunque con bajo riesgo de metástasis.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Gloster, H.M., Jr., “Dermatofibrosarcoma protuberans”, J Am Acad Dermatol, 1996, 35 (3 Pt 1): 355-374; quiz 375-376.

2. Sanmartín, O., Llombart, B., López-Guerrero, J.A., Serra, C., Requena, C. y Guillén, C., “Dermatofibrosarcoma protuberans”, Actas Dermosifiliogr, 2007, 98 (2): 77-87.

3. Love, W.E., Keiler, S.A., Tamburro, J.E., Honda, K., Gosain, A.K. y Bordeaux, J.S., “Surgical management of congenital dermatofibrosarcoma protuberans”, J Am Acad Dermatol, 2009, 61 (6): 1014-1023.

4. Bednar, B., “Storiform neurofibromas of the skin, pigmented and nonpigmented”, Cancer, 1957, 10 (2): 368-376.

5. Reis-Filho, J.S., Milanezi, F., Ferro, J. y Schmitt, F.C., “Pediatric pigmented dermatofibrosarcoma protuberans (Bednar tumour): case report and review of the literature with emphasis on the differential diagnosis”, Pathol Res Pract, 2002, 198 (9): 621-626.

6. Kim, M.S., Han, T.Y., Lee, J.H. y Son, S.J., “A case of congenital dermatofibrosarcoma protuberans”, Korean J Dermatol, 2010, 48 (7): 624-626.

7. Bogucki, B., Neuhaus, I. y Hurst, E.A., “Dermatofibrosarcoma protuberans: a review of the literatura”, Dermatol Surg, 2012, 38 (4): 537-551.

8. Ratner, D., Thomas, C.O., Johnson, T.M., Sondak, V.K., Hamilton, T.A., Nelson, B.R., Swanson, N.A., García, C., Clark, R.E. y Grande, D.J., “Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread”, J Am Acad Dermatol, 1997, 37 (4): 600-613.

9. Kaburagi, Y., Hatta, N., Kawara, S. y Takehara, K., “Pigmented dermatofibrosarcoma protuberance (Bednar tumor) occurring in a Japanese infant”, Dermatology, 1998, 197 (1): 48-51.

10. Fetsch, J.F., Michal, M. y Miettinen, M., “Pigmented (melanotic) neurofibroma: a clinicopathologic and immunohistochemical analysis of 19 lesions from 17 patients”, Am J Surg Pathol, 2000, 3 (24): 331-343.

11. Seo, S.I., Goheen, M. y Min, K.W., “Bednar tumor: report of a case with immunohistochemical and ultrastructural study”, Ultrastructural Pathology, 2003, 27 (3): 205-210.

12. Miller, S.J., Alam, M., Andersen, J., Berg, D., Bichakjian, C.K., Bowen, G.M. et al., “Dermatofibrosarcoma protuberans”, National Comprehensive Cancer Network (nccn) Guidelines, 2012, 10 (3): 312-318.

13. Foroozan, M., Sei, J.F., Amini, M., Beauchet, A. y Saiag, P., “Efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: systematic review”, Arch Dermatol, 2012, 148 (9): 1055-1063.

14. Rutkowski, P. y Debiec-Rychter, M., “Current treatmen options for dermatofibrosarcoma protuberans”, Expert Rev Anticancer Ther, 2015, 15 (8): 901-909.